These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6385188)

  • 1. Allocation of treatment to patients when not all balancing factors are known to the co-ordinating centre.
    van Lier HJ; van Elteren P; Hoitsma AJ; Koene RA
    Stat Med; 1984; 3(3):219-24. PubMed ID: 6385188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
    Mollié A; Hill C
    Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of trials of methods to reduce late renal allograft loss: the price of success.
    Hunsicker LG; Bennett LE
    Kidney Int Suppl; 1995 Dec; 52():S120-3. PubMed ID: 8587274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic renal allograft rejection and clinical trial design.
    Kasiske BL; Massy ZA; Guijarro C; Ma JZ
    Kidney Int Suppl; 1995 Dec; 52():S116-9. PubMed ID: 8587273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
    Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized multidimensional dynamic allocation method.
    Lebowitsch J; Ge Y; Young B; Hu F
    Stat Med; 2012 Dec; 31(28):3537-44. PubMed ID: 22736449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
    Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
    Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
    [No Abstract]   [Full Text] [Related]  

  • 9. High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation.
    Park GD; Bartucci M; Smith MC
    Nephron; 1984; 36(2):80-3. PubMed ID: 6363949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.
    Kreis H; Chkoff N; Chatenoud L; Debure A; Lacombe M; Chrétien Y; Legendre C; Caillat S; Bach JF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1741-4. PubMed ID: 2652570
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of methylprednisolone on first renal allograft rejection.
    Ahonen J; Häyry P; von Willebrand E; Eklund B; Lindström BL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):328-31. PubMed ID: 7022846
    [No Abstract]   [Full Text] [Related]  

  • 13. Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation.
    Sells RA; Scott MH; Prieto M; Bone JM; Evans GM; Millar R; Hills AN
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1173-4. PubMed ID: 2650088
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft irradiation in the treatment of acute rejection of renal transplants: a randomized study.
    Pilepich MV; Anderson CB; Etheredge EE; Sicard GA; Melzer JS; Blum J
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):823-7. PubMed ID: 7050047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR; Blamey RW; Briggs JD; Castro JE; Hamilton DN; Knapp MS; Salaman JR; Sells RA; Williams G; Gowans JL; Peto R; Richards S; Phillips AW; Weinberg AL; Freestone DS
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical issues in the use of dynamic allocation methods for balancing baseline covariates.
    Pond GR
    Br J Cancer; 2011 May; 104(11):1711-5. PubMed ID: 21540857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of prognostic factors in clinical trials.
    Sather HN
    Cancer; 1986 Jul; 58(2 Suppl):461-7. PubMed ID: 3719540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
    Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
    Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
    Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.